Fatemeh Ardeshir Larijani
- Department of Hematology and Medical Oncology
Assistant Professor
Academic Appointment
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from Tehran University of Medical Sciences
- Internal medicine residency from Case Western Reserve University
- Hematology/Oncology Fellowship from Indiana University
- Masters` in clinical science from Indiana University
- Board certified in Internal Medicine, Hematology & Oncology from American Board of Internal Medicine
Research
Publications
-
Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
N Engl J Med Volume: 390 Page(s): 1105 - 1117
03/21/2024 Authors: Cheng A; Kashyap A; Salvator H; Rosen LB; Colby D; Ardeshir-Larijani F; Loehrer PJ; Ding L; Lugo Reyes SO; Riminton S -
Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report.
Clin Lung Cancer Volume: 25 Page(s): 180 - 185.e1
03/01/2024 Authors: Ardeshir-Larijani F; Maniar R; Goyal S; Loehrer PJ; Hou T; DeBrock V; Mesa H -
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
JCO Precis Oncol Volume: 7 Page(s): e2200465
02/01/2023 Authors: Ardeshir-Larijani F; Schneider BP; Althouse SK; Radovich M; Masood A; Perna F; Salman H; Loehrer PJ -
A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139.
Clin Lung Cancer Volume: 23 Page(s): 578 - 584
11/01/2022 Authors: Ardeshir-Larijani F; Althouse SK; Leal T; Feldman LE; Hejleh TA; Patel M; Gentzler RD; Miller AR; Hanna NH -
Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.
Clin Lung Cancer Volume: 22 Page(s): 16 - 22.e1
01/01/2021 Authors: Al-Ahmadi A; Ardeshir-Larijani F; Fu P; Cao S; Lipka MB; Dowlati A; Bruno DS -
Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy.
Volume: 37
05/20/2019 Authors: Ardeshir-Larijani F; Nelson AA; Martin P; Mendiratta P; Sloan AE; Choi S; Mansur DB; Hoimes CJ -
Development of a prognostic risk model for small cell lung cancer: Identification of high-, intermediate-, and low-risk cohorts based on clinical-genomic data.
Volume: 37
05/20/2019 Authors: Ardeshir-Larijani F; Wildey G; Fu P; Dowlati A -
Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
Cancer Med Volume: 8 Page(s): 1459 - 1466
04/01/2019 Authors: Bhateja P; Chiu M; Wildey G; Lipka MB; Fu P; Yang MCL; Ardeshir-Larijani F; Sharma N; Dowlati A -
KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
Clin Lung Cancer Volume: 19 Page(s): e489 - e501
07/01/2018 Authors: Ardeshir-Larijani F; Bhateja P; Lipka MB; Sharma N; Fu P; Dowlati A -
Frequency of NOTCH pathway mutation in primary tumor of SCLC compared to metastatic biopsies and association with better survival.
Volume: 36
05/20/2018 Authors: Ardeshir-Larijani F; Wildey G; Fu P; Bhateja P; Dowlati A